chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received two vaccines in the same arm. After receiving the second shot (flu), patient began to slide out of the chair. Pharmacist caught her and she did not fall or hit anything. She was unresponsive to a verbal question but awakened upon shaking (jumped slightly as if waking up from sleep). She said she remembered feeling the second shot but did not recall falling or being caught by the pharmacist. Patient felt otherwise fine and left after 15 minutes of observation.
Chest pain lasting 5 days after the first shot, then weaning. Chetry pain returned after the second dose, still exist on day 4 after vaccination. Shortness of breath occured with both shots.  Lightheaded the day following both shots, when doing anything physical. Lasted about 4 days. Second shot caused sporadic muscle spasms throughout the body, shooting pains in random places.
Flu like symptoms without throwing up.  This included achy muscles, fatigue and a fever for at least 36 hrs.
Immediately after the vaccination, Patient stated her heart was racing and she felt like she was SOB. Vital signs obtained. No abnormal findings in the objective assessment by staff.  After obtaining vital signs, patient stated she felt better.  Pt was advised to stay at the facility and be monitored by staff. Pt was monitored for approx. 45 mins. Staff advised pt to seek medical help if symptoms return or worsen. Pt agreed and left the facility accompanied and driven by her spouse..
Headache, NauseaVomiting, Reports shooting pain in left arm. Swelling @ injection site Narrative:  Reports shooting pain down left arm, nausea, head ache.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Mar2021 at 16:00 as dose 1, single (Lot number: EP6955), in right arm, on 20Apr2021 at 16:00 as dose 2, single (Lot number: EV8731), in right arm and on 22Nov2021 at 16:00 as dose 3 (booster) single (Lot number: FH8027) at the age of 34 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid (start date=14Jul2022, stop date=18Jul2022). Clinical course: On Jul2022, the patient experienced new covid symptoms after symptoms had almost completely ended. New symptoms included heavy congestion, fatigue, and minor loss of taste and smell. Adverse event start date: 22Jul2022 at 06:00.  No follow-up attempts are possible. No further information is expected.
HCP gave menveo to a patient but only gave the diluent instead of properly mixing the vaccine; HCP gave menveo to a patient but only gave the diluent instead of properly mixing the vaccine; This case was reported by a nurse via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.      Additional Information: GSK receipt date:19-AUG-2022 Reporters comment: The health care professional (HCP) gave menveo diluent only instead of properly mixing the vaccine. Additional Supportive information:The patient received diluent instead of properly mixing the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered
After waking from a nap I felt tingling/numbness going down from injection site to fingers. I was lying down on right side due to extreme pain in left arm. I started to massage my left arm and fingers and I regained feeling to my fingers, but the numbness feeling continues down my arm from injection site to about my wrist.  The pain is around the injection site but reaches as far down as mid bicep.
Patient scheduled for MMR but received Varicella vaccine instead. Error caught and MMR documented as administered on 5/25/22 as well. No adverse effects documented from administration of Varicella vaccine.
Patient seen in ER today c/o swelling of the left side of his face. Unable to lift my top lip on the left side. Also reports tenderness of the left sinus. No visual symptoms, no difficulty swallowing or breathing. Vital signs stable. Dx possible Bell's palsy. Rx with prednisone taper and Valtrex. Interested in VAERS form. Will contact tomorrow for intake information and follow up. Addendum 12/01/2005 spoke with pt 11/29/2005 and he said he was completely symptom free.
Patient presented for 1st dose of Pfizer vaccine today. Patient reported dizziness, difficulty hearing. Patient was assisted to the supine position, onsite EMS was called. Vital signs were taken (below) and were stable. EMS discharged the patient to the care of his mother. Patient continued to be observed following the event, left of own volition.
3 weeks after initial dose  I had a stroke. In hospital 2 weeks in rehab 2 weeks. Many CT Scans and MRI'S. Heart checked,  blood work, neurologist. Reason for stroke unknown
L leg red, swollen, warmth given samples of Zyrtec, Zithromax. Reaction occurred at DTaP injection site.
Breakthrough COVID infection in fully vaccinated patient. Positive date 08/13/2021.
Lips felt swollen and chapped night of vaccine. Didn't think anything of it. Woke up next morning lips still swollen and chapped feeling...small bumps around my lips. Swelling, itching and  dryness continued through day. Used vasoline for dryness and took benadryl for itching and swelling.
Chills, fever, heady, weakness, joint pain, nausea, body aches and fatigue. I drank Tylenol every 6 hours and drank lots of water for around 48 hours after symptoms started. Most of the symptoms went away after the 36-48 hour mark after starting. It?s been currently almost a week after the vaccine and still feel some joint, back pain and a light headache.
PATIENT FAINTED JUST 3-5 MINUTES AFTER RECEIVING THE VACCINE THEN HE REGAINED CONSCIOUS AFTER 2 MINUTES OF FAINTING
Started out that night with chills and joint pains... then the next day (2/10), it was the nasty headache, tired, chills/ then was really hot (low grade temp) & then back to chills. Today 2/11, just a little tired and chilled and a slight headache but much better than yesterday.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of the patient was 26.56 years.  Concomitant products were not provided.  On 15-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 6-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 9-May-2021.  On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 AM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42 and 5 PM: 42.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Feeling injection sight noticed large mound. Looked and there was a 4" round circle mound looking like a rash. Next day it grew to about 5". It is now fading out about 5 days later. Slightly itchy the first couple days. Not bad.
Right upper leg 4cm area of redness. Slightly warm to touch. Feels hard.
dementia is getting worse; headaches; This is a spontaneous report from a contactable consumer (patient's child). An 81-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 23Jan2021 (at the age of 81 years old) at a single dose for covid-19 immunization. Medical history included dialysis from 2015 and ongoing and ongoing dementia. The patient's concomitant medications were not reported. On unspecified date in Jan2021, the patient started getting headaches and that her dementia is getting worse. Therapeutic measures were taken as a result of headaches which included BC powder and acetaminophen (TYLENOL). Outcome of the events was unknown.   Information on the lot/ batch number has been requested.
Patient received Pfizer bivalent vaccine and reported facial tightness around cheeks and eyes.  Left arm weakness; difficulty swallowing.
really almost died; swollen up again; penis, scrotum, stomach, legs and arms were swollen; penis, scrotum, stomach, legs and arms were swollen; penis, scrotum, stomach, legs and arms were swollen; penis, scrotum, stomach, legs and arms were swollen; unable to walk; short of breath; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A 60 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2 , single for covid-19 immunisation. Relevant medical history included: "leukemia" (unspecified if ongoing), notes: underlying medical condition of leukemia, which is in remission. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 immunization, reaction(s): "lymph nodes and everything were swollen", "swelling head to toe". The following information was reported: NEAR DEATH EXPERIENCE (hospitalization, medically significant), outcome "unknown", described as "really almost died"; SWELLING (hospitalization), outcome "unknown", described as "swollen up again"; PENILE SWELLING (hospitalization), SCROTAL SWELLING (hospitalization), ABDOMINAL DISTENSION (hospitalization), PERIPHERAL SWELLING (hospitalization), outcome "unknown" and all described as "penis, scrotum, stomach, legs and arms were swollen"; GAIT INABILITY (hospitalization), outcome "unknown", described as "unable to walk"; DYSPNOEA (hospitalization), outcome "unknown", described as "short of breath". Therapeutic measures were taken as a result of swelling, penile swelling, scrotal swelling, abdominal distension, peripheral swelling.  Clinical course: Reporter reported that the patient had a underlying condition but it was suggested that he take the vaccine anyways. The patient took the second dose and waited for 30 minutes. the reporter stated, by the time patient got home he had swollen up again and this time ended up hospitalized for 2 months. the reporter stated some of the swelling and shortness of breath still persist today and he was released from the hospital in Nov. the patient still had complication from the swelling, the patient had been placed on medication but the swelling still persist. Stated as, he really almost died. the patient's penis swelled to the size of a liter bottle and his scrotum swelled to the size of a cabbage.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a county health nurse as confirmed by a school nurse and patient's mother concerning a 9 year old male patient with unknown medical history, drug reactions or allergies who on 25-FEB-2000 was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (lot number 632369/1461J) subcutaneously in the right arm. No concomitant medications were reported. On 27-FEB-2008, the patient had a generalized varicella like rash with 44 lesions, but no fever. All lesions were crusted over. The patient experienced no problems and had recovered on an unknown date. It was reported that patient sought medical attention "in the office." There was no product quality complaint. No further information is available.
Information has been received from a registered nurse concerning a female patient who on an unspecified date was vaccinated with a dose of GARDASIL (Lot Number: 667866/1437Z). On an unspecified date the patient experienced pain in her arm after receiving the GARDASIL. It was unspecified whether the patient sought medical attention. At the time of the report, the patient's present status was unknown. A lot check has been initiated. This is one of several reports received from the same source. Additional information has been requested.
sore arm the evening after the shot but gone in 24 hours.  About 4 days later malaise, headache, swollen lymph note on right side (shot on the left) so tired, no appetite
2 week hx right facial paralysis. Preceded by URI symptoms and mild right ear pain. Flu, Hep A & HPV shots 1-2 weeks prior to symptoms. Previous flu shots, Hep A & HPV without problems. Wears glasses. Bell's Palsy handout given. Eye care/protection discussed, VAERS given. F/U no improvement referral - Neurology.
Toothache and thinks crown will need to be replaced; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TOOTHACHE (non-serious), outcome "unknown", described as "Toothache and thinks crown will need to be replaced". Therapeutic measures were not taken as a result of toothache. Additional information: The patient stated that he has an appointment for second shot on Thursday and thinks he will need a crown replaced. The patient would like to know if there is any problem with getting dental work before then or should he wait.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient admitted 5/12 for ataxia since 5/9 after he was initiated on Trulicity. He has been dizzy with some blurred vision. Reports a headache and has had some shortness of breath, coughing, nausea and vomiting with dizziness. During dizziness work-up, the patient found to have unremarkable CXR and head CT without acute changes, but was noted to have chronic multifocal occlusions of the cervical and intracranial portions of the right vetebral atery on CTA head/neck. Patient was incidentally found to have COVID infection on 5/12 while inpatient. Given that his infection was not causing respiratory symptoms and the patient felt well after blood administration, COVID was not actively treated. Discharged on 5/14/22.
10/1/12 scattered maculovesicles - drying on upper back, scalp, arms, and trunk. Approximately 20 spots.
Patient reported dizziness and was interviewed by pharmacist. she denied hx of medical conditions. I took her BP and it was 151/90. Patient then experienced loss of consciousness for < 30 seconds. she was then referred to EMT
a box / was left with 2 vials of antigen /believes the adjuvant portion was only administered; a box / was left with 2 vials of antigen /believes the adjuvant portion was only administered; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were reported as follows: The age group was not reported but was selected as an adult as per vaccine indication. The age at vaccination was not reported. The nurse reported that during monthly inventory found out that a box of Shingrix was left with vial of antigen and believes the adjuvant portion was only administered to patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The nurse wanted to know if patient required to be revaccinated. The reporter consented to follow up. No further information was reported. This case had been linked with US2021084235, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021084235:same reporter
bruise devel @ inj site  noc of vax date;mom stated it was swollen & hard;states bruises bigger;discolored area size of quarter on rt thigh;tender, hard area warm;mass is deep;
SP vaccine 1/28/02; 02/04/2002-redness, swelling, increased drainage, 1 cm lymphadenopathy, Ceftin 250 mg 1 bid x 5d; 2/6/02-cellulitis -resolved.
I do not have brand information, lot #, etc.    Her right arm was sore that day. The left arm was much more sore than expected. Kept her awake all night. Thursday she felt very sick all day, the left arm was very sore. Last night (Thursday) it started to swell. She had night sweats all night last night. She is now having runny nose, sore throat, very red, swollen left upper arm, left upper chest and axilla. She also feels very sick today
Per H&P: 25 y.o. female  with PMHx of AIHA requiring recent hospitalization and asthma who presents with symptomatic anemia and Hb of 4.8 on outpatient labs from 11/8.    Patient had a recent hospitalization at hospital in October 2021.  She had been experiencing increased lightheadedness, fatigue, weakness, and headaches and was found to have a hemoglobin of 6.6.  As she is a denomination  she deferred any blood transfusions.  Work-up demonstrated positive Coombs, CD3, parvovirus IgG, decreased haptoglobin (<8), erythropoietin 77, and elevated reticulocyte site count.  Hematology was consulted and started methylprednisolone, IVIG, EPO x2.  IR BM biopsy showed normocellular marrow with trilineage hematopoiesis, elevated reticulin fibrosis, no elevated blasts.  She was discharged on a prednisone 60 taper which she has completed and scheduled outpatient hematology follow-up.  Patient reports that she only experienced minimal improvement with treatment during that hospitalization.     She notes that following that hospitalization, she continued to experience weakness and numbness in her legs, tremors in her extremities when exerting herself for long periods, and dyspnea on exertion.  She states that she feels intermittently fatigued but was noticeably more fatigued yesterday.  She continues to have occasional headaches which is relieved with migraine medication.  Also notes intermittent loss of appetite. Reports that she feels better overall than compared to her last admission. Denies any chest pain, lightheadedness, or shortness of breath currently.  Denies any signs of bleeding.  Patient has been taking iron supplements and completed her steroid taper on 11/7.  Last menstrual period was earlier this month and she notes that flow was more inconsistent but does not feel like menstruation was heavier than normal.  Reports that her twin sister also has hx of anemia which has required hospitalization in the past but is unaware of any other family history of hematological conditions. She is currently on leave of absence from work due to her medical issues until next week.
Swollen lymph node in left arm pit.  Presented day after vaccine. Swelling, pain, and warm to touch.
Flu-like symptoms for two days after receiving vaccine, including body aches, extreme fatigue, 100.3 fever on day after vaccine, diarrhea on second day after vaccine.  General brain-fog
In accordance with the patient, MF stated that he was given Prednisone by his physician for the tendonitis.
This spontaneous report has been received from a Registered Nurse referring to a 14 year old female patient. Information about concurrent condition, concomitant medication and medical history was not provided. On 02-JUN-2016, the first dose in the series of GARDASIL 9 was administered to the patient (dose and route were not reported). On 14-JUN-2016, the patient was ordered to be administered with VARIVAX and was inadvertently vaccinated with her second dose of GARDASIL 9 (lot # M007728, expired date 21-MAR-2018, once) intramuscularly. No adverse event was reported. The patient did not seek medical attention. No treatment was given to the patient. It was also reported that vaccination with GARDASIL 9 would be continued. Additional information has been requested.